Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

NCT00005053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: glufosfamide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC